Tiziano Barbui - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Tiziano Barbui's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Tiziano Barbui
Verified
Editorial Board Member, Blood Cancer Journal
Italy
Beats
Fitness, Mental health, women's issues race, travel and other lifestyle topics. food
Content
Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification - Blood Cancer Journal
By Daniel A. Arber, Ayalew Tefferi, Alessandro Vannucchi, Tiziano Barbui| Nature Verified AbstractA lively discussion persists regarding the diagnostic criteria for essential thrombocythemia (ET), primary myelofibrosis (PMF) and polycythemia vera (PV), particularly in relation to early/pre-fibrotic myelofibrosis (pre-PMF), a disease entity initially introduced in 2001 by the 3rd edition of the World Health Organization (WHO) classification. The definition and criteria used to diagnose pre-PMF have been progressively modified over time
Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis - Blood Cancer Journal
By Tiziano Barbui, Alessandra Carobbio, Alessandro Vannucchi, Paola Guglielmelli, Alessandro Rambaldi, Naseema Gangat Verified| Nature Verified AbstractWe analyzed the neutrophil-to-lymphocyte ratio (NLR) in 1508 patients with PV and found that those with an NLR ≥ 5 were generally older, had a longer disease history, and had higher cardiovascular risk factors, more arterial thrombosis, and more aggressive blood counts, indicating a more proliferative disease
Company Info
Blood Cancer Journal
Hoboken, New Jersey, United States
'+1 201-748-6000